KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Debt Ratio (2016 - 2020)

Historic Debt Ratio for Nektar Therapeutics (NKTR) over the last 10 years, with Q1 2020 value amounting to 0.27.

  • Nektar Therapeutics' Debt Ratio rose 13608.23% to 0.27 in Q1 2020 from the same period last year, while for Mar 2020 it was 0.27, marking a year-over-year increase of 13608.23%. This contributed to the annual value of 0.25 for FY2019, which is 12143.85% up from last year.
  • Nektar Therapeutics' Debt Ratio amounted to 0.27 in Q1 2020, which was up 13608.23% from 0.25 recorded in Q4 2019.
  • Over the past 5 years, Nektar Therapeutics' Debt Ratio peaked at 0.57 during Q3 2016, and registered a low of 0.11 during Q2 2018.
  • Over the past 5 years, Nektar Therapeutics' median Debt Ratio value was 0.42 (recorded in 2017), while the average stood at 0.33.
  • Its Debt Ratio has fluctuated over the past 5 years, first crashed by 7928.09% in 2018, then surged by 13608.23% in 2020.
  • Nektar Therapeutics' Debt Ratio (Quarter) stood at 0.43 in 2016, then rose by 12.59% to 0.48 in 2017, then crashed by 76.17% to 0.11 in 2018, then skyrocketed by 121.44% to 0.25 in 2019, then increased by 6.0% to 0.27 in 2020.
  • Its Debt Ratio was 0.27 in Q1 2020, compared to 0.25 in Q4 2019 and 0.12 in Q3 2019.